196 related articles for article (PubMed ID: 16878153)
1. A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
Mazzieri R; Furlan F; D'Alessio S; Zonari E; Talotta F; Verde P; Blasi F
Oncogene; 2007 Feb; 26(5):725-32. PubMed ID: 16878153
[TBL] [Abstract][Full Text] [Related]
2. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
[TBL] [Abstract][Full Text] [Related]
3. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
4. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
Pantoja C; Serrano M
Oncogene; 1999 Sep; 18(35):4974-82. PubMed ID: 10490832
[TBL] [Abstract][Full Text] [Related]
5. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.
Adachi Y; Chandrasekar N; Kin Y; Lakka SS; Mohanam S; Yanamandra N; Mohan PM; Fuller GN; Fang B; Fueyo J; Dinh DH; Olivero WC; Tamiya T; Ohmoto T; Kyritsis AP; Rao JS
Oncogene; 2002 Jan; 21(1):87-95. PubMed ID: 11791179
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
7. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS
Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878
[TBL] [Abstract][Full Text] [Related]
9. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells.
Kim MH; Cho HS; Jung M; Hong MH; Lee SK; Shin BA; Ahn BW; Jung YD
Int J Oncol; 2005 Jun; 26(6):1669-74. PubMed ID: 15870884
[TBL] [Abstract][Full Text] [Related]
10. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of tumours derived from rasV12/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development.
Vasseur S; Malicet C; Calvo EL; Dagorn JC; Iovanna JL
Mol Cancer; 2005 Jan; 4(1):4. PubMed ID: 15651998
[TBL] [Abstract][Full Text] [Related]
12. Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.
Margheri F; D'Alessio S; Serratí S; Pucci M; Annunziato F; Cosmi L; Liotta F; Angeli R; Angelucci A; Gravina GL; Rucci N; Bologna M; Teti A; Monia B; Fibbi G; Del Rosso M
Gene Ther; 2005 Apr; 12(8):702-14. PubMed ID: 15674398
[TBL] [Abstract][Full Text] [Related]
13. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
Lakka SS; Rajagopal R; Rajan MK; Mohan PM; Adachi Y; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Roth JA; Yung WK; Kyritsis AP; Rao JS
Clin Cancer Res; 2001 Apr; 7(4):1087-93. PubMed ID: 11309361
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
Besch R; Berking C; Kammerbauer C; Degitz K
Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
[TBL] [Abstract][Full Text] [Related]
17. Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1.
Jamaluddin MS
Biochem Biophys Res Commun; 2006 Sep; 348(2):618-27. PubMed ID: 16893520
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Rac1 activation by the low density lipoprotein receptor-related protein.
Ma Z; Thomas KS; Webb DJ; Moravec R; Salicioni AM; Mars WM; Gonias SL
J Cell Biol; 2002 Dec; 159(6):1061-70. PubMed ID: 12499359
[TBL] [Abstract][Full Text] [Related]
19. High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice.
Lutz V; Reuning U; Krüger A; Luther T; von Steinburg SP; Graeff H; Schmitt M; Wilhelm OG; Magdolen V
Biol Chem; 2001 May; 382(5):789-98. PubMed ID: 11517932
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells.
de Bock CE; Lin Z; Itoh T; Morris D; Murrell G; Wang Y
FEBS J; 2005 Jul; 272(14):3572-82. PubMed ID: 16008557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
